Table 1.
Summary of the clinicopathologic features of the study series (n = 30)
| Age (range) | 65 years (50–83 years) |
| Menopausal status | |
| Pre‐menopausal | 1 |
| Post‐menopausal | 29 |
| Tumour size (range) | 6.0 cm (2.3 – 15.0 cm) |
| Sarcoma component | |
| Homologous | 14 |
| Heterologous | 16 |
| Rhabdomyosarcoma | 5 |
| Chondrosarcoma | 3 |
| Osteosarcoma | 3 |
| >1 sarcoma type | 5 |
| Metastases | |
| Absent | 19 |
| Present | 11 |
| Pelvic metastases | 6 |
| Carcinoma only | 3 |
| Sarcoma only | 1 |
| Carcinoma and sarcoma | 2 |
| Distant metastases (beyond pelvis) | 5 |
| Carcinoma only | 5 |
| Sarcoma only | 0 |
| Carcinoma and sarcoma | 0 |
| Lymph nodes | |
| Benign | 12 |
| Positive for metastases | 3 |
| Not taken | 15 |
| Pelvic washings | |
| Negative | 17 |
| Positive | 9 |
| Not taken | 4 |
| Clinical Stage | |
| I | 15 |
| II | 0 |
| III | 10 |
| IV | 5 |